Walking intervention can lower BP in sedentary older adults
Oct 10, 2023
Both systolic and diastolic blood pressure may improve among older adults taking an additional 3,000 steps/day.
Tech can help measure paces for seniors with heart issues, but doesn’t supply the final step: long-term...
By
Aaron Dorman
Sep 28, 2023
New studies indicate devices can help residents stay fit and avoid heart emergencies, but motivation may need to come from caregivers.
Nitrate-enriched beetroot juice produces reduction in systolic BP in COPD
Dec 20, 2023
Active treatment lowered SBP, improved 6-minute walk test and improved measures of endothelial function.
Healthtech Institute creates 14-member collaborative, announces new study on tech and hypertension
By
Aaron Dorman
Mar 01, 2024
The Peterson Health Tech Institute jointly announced a new digital health collaborative and plans for two new case studies.
Prehospital reduction in BP does not improve stroke outcomes
May 20, 2024
The findings were seen in patients with suspected acute stroke with elevated systolic blood pressure.
Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
Antihypertensives linked to eczematous dermatitis in seniors
May 24, 2024
The largest effect sizes were seen for diuretics and calcium channel blockers, and the smallest were seen for ACE inhibitors and beta-blockers.
Salt substitute can reduce incidence of hypertension among seniors
Feb 12, 2024
No increase was seen in the incidence of hypotension episodes with replacement of salt by a potassium-enriched substitute.
Telehealth, monitoring tech, make a meaningful difference in helping seniors with hypertension: study
By
Aaron Dorman
Feb 21, 2024
Digital health interventions make a positive impact in managing hypertension among seniors, according to a study released last week.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.